Literature DB >> 18464929

p21Cip1 modulates arterial wound repair through the stromal cell-derived factor-1/CXCR4 axis in mice.

Michelle Olive1, Jason A Mellad, Leilani E Beltran, Mingchao Ma, Thomas Cimato, Audrey C Noguchi, Hong San, Richard Childs, Jason C Kovacic, Manfred Boehm.   

Abstract

Cyclin-dependent kinase inhibitors, including p21Cip1, are implicated in cell turnover and are active players in cardiovascular wound repair. Here, we show that p21Cip1 orchestrates the complex interactions between local vascular and circulating immune cells during vascular wound repair. In response to femoral artery mechanical injury, mice with homozygous deletion of p21Cip1 displayed accelerated proliferation of VSMCs and increased immune cell infiltration. BM transplantation experiments indicated that local p21Cip1 plays a pivotal role in restraining excessive proliferation during vascular wound repair. Increased local vascular stromal cell-derived factor-1 (SDF-1) levels were observed after femoral artery injury in p21+/+ and p21-/- mice, although this was significantly greater in p21-/- animals. In addition, disruption of SDF-1/CXCR4 signaling inhibited the proliferative response during vascular remodeling in both p21+/+ and p21-/- mice. We provide evidence that the JAK/STAT signaling pathway is an important regulator of vascular SDF-1 levels and that p21Cip1 inhibits STAT3 binding to the STAT-binding site within the murine SDF-1 promoter. Collectively, these results suggest that p21Cip1 activity is essential for the regulation of cell proliferation and inflammation after arterial injury in local vascular cells and that the SDF-1/CXCR4 signaling system is a key mediator of vascular proliferation in response to injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18464929      PMCID: PMC2373418          DOI: 10.1172/JCI31244

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  66 in total

Review 1.  CDK inhibitors: positive and negative regulators of G1-phase progression.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

2.  The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway.

Authors:  A J Vila-Coro; J M Rodríguez-Frade; A Martín De Ana; M C Moreno-Ortíz; C Martínez-A; M Mellado
Journal:  FASEB J       Date:  1999-10       Impact factor: 5.191

Review 3.  Living with or without cyclins and cyclin-dependent kinases.

Authors:  Charles J Sherr; James M Roberts
Journal:  Genes Dev       Date:  2004-11-15       Impact factor: 11.361

4.  Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis.

Authors:  Aksam J Merched; Lawrence Chan
Journal:  Circulation       Date:  2004-12-13       Impact factor: 29.690

5.  New functional activities for the p21 family of CDK inhibitors.

Authors:  J LaBaer; M D Garrett; L F Stevenson; J M Slingerland; C Sandhu; H S Chou; A Fattaey; E Harlow
Journal:  Genes Dev       Date:  1997-04-01       Impact factor: 11.361

6.  Control of E2F activity by p21Waf1/Cip1.

Authors:  L Delavaine; N B La Thangue
Journal:  Oncogene       Date:  1999-09-23       Impact factor: 9.867

7.  The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts.

Authors:  M Cheng; P Olivier; J A Diehl; M Fero; M F Roussel; J M Roberts; C J Sherr
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

8.  Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury.

Authors:  J Dawn Abbott; Yan Huang; Dingang Liu; Reed Hickey; Diane S Krause; Frank J Giordano
Journal:  Circulation       Date:  2004-11-08       Impact factor: 29.690

9.  Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP.

Authors:  A Suzuki; Y Tsutomi; K Akahane; T Araki; M Miura
Journal:  Oncogene       Date:  1998-08-27       Impact factor: 9.867

10.  The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood.

Authors:  A Aiuti; I J Webb; C Bleul; T Springer; J C Gutierrez-Ramos
Journal:  J Exp Med       Date:  1997-01-06       Impact factor: 14.307

View more
  29 in total

Review 1.  The Role of Chemokines in Fibrotic Wound Healing.

Authors:  Jie Ding; Edward E Tredget
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-11-01       Impact factor: 4.730

2.  p53 functions in endothelial cells to prevent radiation-induced myocardial injury in mice.

Authors:  Chang-Lung Lee; Everett J Moding; Kyle C Cuneo; Yifan Li; Julie M Sullivan; Lan Mao; Iman Washington; Laura B Jeffords; Rafaela C Rodrigues; Yan Ma; Shiva Das; Christopher D Kontos; Yongbaek Kim; Howard A Rockman; David G Kirsch
Journal:  Sci Signal       Date:  2012-07-24       Impact factor: 8.192

3.  S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.

Authors:  Jiehui Deng; Yong Liu; Heehyoung Lee; Andreas Herrmann; Wang Zhang; Chunyan Zhang; Shudan Shen; Saul J Priceman; Maciej Kujawski; Sumanta K Pal; Andrew Raubitschek; Dave S B Hoon; Stephen Forman; Robert A Figlin; Jie Liu; Richard Jove; Hua Yu
Journal:  Cancer Cell       Date:  2012-05-15       Impact factor: 31.743

4.  INK4a knockout mice exhibit increased fibrosis under normal conditions and in response to unilateral ureteral obstruction.

Authors:  Jesse M Wolstein; David H Lee; Jennine Michaud; Venessa Buot; Beth Stefanchik; Matthew D Plotkin
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-22

5.  SDF-1 activates papillary label-retaining cells during kidney repair from injury.

Authors:  Juan A Oliver; Omar Maarouf; Faisal H Cheema; Charles Liu; Qing-Yin Zhang; Carl Kraus; M Zeeshan Afzal; Mamoona Firdous; Apostolos Klinakis; Argiris Efstratiadis; Qais Al-Awqati
Journal:  Am J Physiol Renal Physiol       Date:  2012-03-28

6.  HDAC2 phosphorylation-dependent Klf5 deacetylation and RARα acetylation induced by RAR agonist switch the transcription regulatory programs of p21 in VSMCs.

Authors:  Bin Zheng; Mei Han; Ya-Nan Shu; Ying-Jie Li; Sui-Bing Miao; Xin-Hua Zhang; Hui-Jing Shi; Tian Zhang; Jin-Kun Wen
Journal:  Cell Res       Date:  2011-03-08       Impact factor: 25.617

7.  Increase in GLUT1 in smooth muscle alters vascular contractility and increases inflammation in response to vascular injury.

Authors:  Neeta Adhikari; David L Basi; Marjorie Carlson; Ami Mariash; Zhigang Hong; Ute Lehman; Sureni Mullegama; Edward K Weir; Jennifer L Hall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-10-14       Impact factor: 8.311

8.  VEGFR1/CXCR4-positive progenitor cells modulate local inflammation and augment tissue perfusion by a SDF-1-dependent mechanism.

Authors:  Andrew Wragg; Jason A Mellad; Leilani E Beltran; Mikhail Konoplyannikov; Hong San; Sherry Boozer; Robert J Deans; Anthony Mathur; Robert J Lederman; Jason C Kovacic; Manfred Boehm
Journal:  J Mol Med (Berl)       Date:  2008-08-09       Impact factor: 4.599

9.  Stromal cell-derived factor-1 promoted angiogenesis and inflammatory cell infiltration in aneurysm walls.

Authors:  Brian L Hoh; Koji Hosaka; Daniel P Downes; Kamil W Nowicki; Erin N Wilmer; Gregory J Velat; Edward W Scott
Journal:  J Neurosurg       Date:  2013-10-25       Impact factor: 5.115

10.  TGF-β signaling mediates endothelial-to-mesenchymal transition (EndMT) during vein graft remodeling.

Authors:  Brian C Cooley; Jose Nevado; Jason Mellad; Dan Yang; Cynthia St Hilaire; Alejandra Negro; Fang Fang; Guibin Chen; Hong San; Avram D Walts; Robin L Schwartzbeck; Brandi Taylor; Jan D Lanzer; Andrew Wragg; Abdalla Elagha; Leilani E Beltran; Colin Berry; Robert Feil; Renu Virmani; Elena Ladich; Jason C Kovacic; Manfred Boehm
Journal:  Sci Transl Med       Date:  2014-03-12       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.